Per1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Per1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
.infobox .infobox-gene [@circadiancell2019]
Overview
Mermaid diagram (expand to render)
PER1 (Period Circadian Regulator 1) is a core circadian clock gene essential for maintaining daily rhythms in mammals. This gene encodes a protein that plays a critical role in the negative feedback loop governing the circadian clock, regulating not only sleep-wake cycles but also numerous physiological processes including hormone secretion, metabolism, and cellular function. Dysregulation of PER1 has been implicated in various neurodegenerative diseases, sleep disorders, and metabolic conditions, making it an important therapeutic target [1][2].
Function
PER1 (Period Circadian Regulator 1) is a core component of the mammalian circadian clock. Together with PER2 and PER3, PER1 forms the negative feedback loop that generates circadian rhythms in gene expression and behavior[@per2020].
Molecular Clock Mechanism
The circadian clock operates through a transcription-translation feedback loop:
Positive Arm: CLOCK and BMAL1 drive transcription of PER and CRY genes
Negative Feedback: PER proteins accumulate, form complexes with CRY, and inhibit CLOCK/BMAL1
Post-translational Regulation: Phosphorylation, ubiquitination, and degradation cycle PER proteins
Functions Beyond Circadian Rhythm
PER1 has additional roles:
Cell Cycle Regulation: Links circadian clock to cell proliferation[@circadiancell2019]
Metabolism: Regulates glucose homeostasis and lipid metabolism
Memory: Involved in hippocampal synaptic plasticity
DNA Damage Response: PER1 participates in DNA repair pathways
Role in Neurodegeneration
Alzheimer's Disease
Circadian disturbances are common in AD, and PER1 dysregulation contributes to:
Sleep-wake cycle fragmentation
Sundowning syndrome
Cognitive decline progression[@per2021]
Interaction with amyloid pathology
Parkinson's Disease
PER1 alterations in PD:
Disrupted circadian rhythms in PD patients
Altered PER1 expression in dopaminergic [neurons](/entities/neurons)
Links to sleep disorders in PD
Stroke and Brain Injury
PER1 responds to brain injury:
Acute ischemia alters PER1 expression
Circadian timing affects stroke outcomes
Therapeutic potential of chronotherapy
Therapeutic Implications
Chronotherapy
Timing of treatments based on circadian rhythms:
Optimizing drug administration times
Light therapy for circadian disorders
Circadian-aligned behavioral interventions
Cancer
PER1 dysregulation in cancer:
Altered PER1 in various tumors
Links between circadian disruption and carcinogenesis
[PER1 in circadian rhythm (2020)](https://doi.org/10.1016/j.tics.2020.06.008)
[Circadian clock and cell cycle (2019)](https://doi.org/10.1016/j.tcb.2019.05.003)
[PER1 in Alzheimer's disease (2021)](https://pubmed.ncbi.nlm.nih.gov/33567890/)
[Circadian disruption in neurodegeneration (2022)](https://pubmed.ncbi.nlm.nih.gov/35218945/)
Background
The study of Per1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data